Literature DB >> 25378175

Transnitrosylation from DJ-1 to PTEN attenuates neuronal cell death in parkinson's disease models.

Min Sik Choi1, Tomohiro Nakamura1, Seung-Je Cho2, Xuemei Han3, Emily A Holland1, Jing Qu1, Gregory A Petsko4, John R Yates3, Robert C Liddington2, Stuart A Lipton5.   

Abstract

Emerging evidence suggests that oxidative/nitrosative stress, as occurs during aging, contributes to the pathogenesis of Parkinson's disease (PD). In contrast, detoxification of reactive oxygen species and reactive nitrogen species can protect neurons. DJ-1 has been identified as one of several recessively inherited genes whose mutation can cause familial PD, and inactivation of DJ-1 renders neurons more susceptible to oxidative stress and cell death. DJ-1 is also known to regulate the activity of the phosphatase and tensin homolog (PTEN), which plays a critical role in neuronal cell death in response to various insults. However, mechanistic details delineating how DJ-1 regulates PTEN activity remain unknown. Here, we report that PTEN phosphatase activity is inhibited via a transnitrosylation reaction [i.e., transfer of a nitric oxide (NO) group from the cysteine residue of one protein to another]. Specifically, we show that DJ-1 is S-nitrosylated (forming SNO-DJ-1); subsequently, the NO group is transferred from DJ-1 to PTEN by transnitrosylation. Moreover, we detect SNO-PTEN in human brains with sporadic PD. Using x-ray crystallography and site-directed mutagenesis, we find that Cys106 is the site of S-nitrosylation on DJ-1 and that mutation of this site inhibits transnitrosylation to PTEN. Importantly, S-nitrosylation of PTEN decreases its phosphatase activity, thus promoting cell survival. These findings provide mechanistic insight into the neuroprotective role of SNO-DJ-1 by elucidating how DJ-1 detoxifies NO via transnitrosylation to PTEN. Dysfunctional DJ-1, which lacks this transnitrosylation activity due to mutation or prior oxidation (e.g., sulfonation) of the critical cysteine thiol, could thus contribute to neurodegenerative disorders like PD.
Copyright © 2014 the authors 0270-6474/14/3415123-09$15.00/0.

Entities:  

Keywords:  DJ-1; PTEN; Parkinson's disease; S-nitrosylation; nitric oxide; transnitrosylation

Mesh:

Substances:

Year:  2014        PMID: 25378175      PMCID: PMC4220036          DOI: 10.1523/JNEUROSCI.4751-13.2014

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  39 in total

1.  The PTEN/MMAC1 tumor suppressor induces cell death that is rescued by the AKT/protein kinase B oncogene.

Authors:  J Li; L Simpson; M Takahashi; C Miliaresis; M P Myers; N Tonks; R Parsons
Journal:  Cancer Res       Date:  1998-12-15       Impact factor: 12.701

2.  DJ-1 promotes the proteasomal degradation of Fis1: implications of DJ-1 in neuronal protection.

Authors:  Qiang Zhang; Junbing Wu; Rong Wu; Jun Ma; Guiping Du; Renjie Jiao; Yong Tian; Zheng Zheng; Zengqiang Yuan
Journal:  Biochem J       Date:  2012-10-15       Impact factor: 3.857

3.  DJ-1, a novel regulator of the tumor suppressor PTEN.

Authors:  Raymond H Kim; Malte Peters; YingJu Jang; Wei Shi; Melania Pintilie; Graham C Fletcher; Carmela DeLuca; Jennifer Liepa; Lily Zhou; Bryan Snow; Richard C Binari; Armen S Manoukian; Mark R Bray; Fei-Fei Liu; Ming-Sound Tsao; Tak W Mak
Journal:  Cancer Cell       Date:  2005-03       Impact factor: 31.743

4.  Protein S-nitrosylation: a physiological signal for neuronal nitric oxide.

Authors:  S R Jaffrey; H Erdjument-Bromage; C D Ferris; P Tempst; S H Snyder
Journal:  Nat Cell Biol       Date:  2001-02       Impact factor: 28.824

5.  DJ-1 gene deletion reveals that DJ-1 is an atypical peroxiredoxin-like peroxidase.

Authors:  Eva Andres-Mateos; Celine Perier; Li Zhang; Beatrice Blanchard-Fillion; Todd M Greco; Bobby Thomas; Han Seok Ko; Masayuki Sasaki; Harry Ischiropoulos; Serge Przedborski; Ted M Dawson; Valina L Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-31       Impact factor: 11.205

Review 6.  Actions of redox-related congeners of nitric oxide at the NMDA receptor.

Authors:  S A Lipton; J S Stamler
Journal:  Neuropharmacology       Date:  1994-11       Impact factor: 5.250

7.  Selective deletion of PTEN in dopamine neurons leads to trophic effects and adaptation of striatal medium spiny projecting neurons.

Authors:  Oscar Diaz-Ruiz; Agustin Zapata; Lufei Shan; YaJun Zhang; Andreas C Tomac; Nasir Malik; Fidel de la Cruz; Cristina M Bäckman
Journal:  PLoS One       Date:  2009-09-11       Impact factor: 3.240

8.  NO signaling and S-nitrosylation regulate PTEN inhibition in neurodegeneration.

Authors:  Young-Don Kwak; Tao Ma; Shiyong Diao; Xue Zhang; Yaomin Chen; Janet Hsu; Stuart A Lipton; Eliezer Masliah; Huaxi Xu; Francesca-Fang Liao
Journal:  Mol Neurodegener       Date:  2010-11-10       Impact factor: 14.195

Review 9.  Aberrant protein s-nitrosylation in neurodegenerative diseases.

Authors:  Tomohiro Nakamura; Shichun Tu; Mohd Waseem Akhtar; Carmen R Sunico; Shu-Ichi Okamoto; Stuart A Lipton
Journal:  Neuron       Date:  2013-05-22       Impact factor: 17.173

10.  Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism.

Authors:  Vincenzo Bonifati; Patrizia Rizzu; Marijke J van Baren; Onno Schaap; Guido J Breedveld; Elmar Krieger; Marieke C J Dekker; Ferdinando Squitieri; Pablo Ibanez; Marijke Joosse; Jeroen W van Dongen; Nicola Vanacore; John C van Swieten; Alexis Brice; Giuseppe Meco; Cornelia M van Duijn; Ben A Oostra; Peter Heutink
Journal:  Science       Date:  2002-11-21       Impact factor: 47.728

View more
  37 in total

1.  Epidermal Growth Factor-dependent Activation of the Extracellular Signal-regulated Kinase Pathway by DJ-1 Protein through Its Direct Binding to c-Raf Protein.

Authors:  Kazuko Takahashi-Niki; Izumi Kato-Ose; Hiroaki Murata; Hiroshi Maita; Sanae M M Iguchi-Ariga; Hiroyoshi Ariga
Journal:  J Biol Chem       Date:  2015-06-05       Impact factor: 5.157

Review 2.  The functions of tumor suppressor PTEN in innate and adaptive immunity.

Authors:  Lang Chen; Deyin Guo
Journal:  Cell Mol Immunol       Date:  2017-06-26       Impact factor: 11.530

Review 3.  Protein S-Nitrosylation: Determinants of Specificity and Enzymatic Regulation of S-Nitrosothiol-Based Signaling.

Authors:  Colin T Stomberski; Douglas T Hess; Jonathan S Stamler
Journal:  Antioxid Redox Signal       Date:  2018-01-10       Impact factor: 8.401

4.  Regulation of Signal Transduction by DJ-1.

Authors:  Stephanie E Oh; M Maral Mouradian
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

5.  DJ-1/PARK7, But Not Its L166P Mutant Linked to Autosomal Recessive Parkinsonism, Modulates the Transcriptional Activity of the Orphan Nuclear Receptor Nurr1 In Vitro and In Vivo.

Authors:  Lingling Lu; Shasha Zhao; Ge Gao; Xiaohong Sun; Huanying Zhao; Hui Yang
Journal:  Mol Neurobiol       Date:  2016-02-12       Impact factor: 5.590

Review 6.  S-Nitrosylation Regulates Cell Survival and Death in the Central Nervous System.

Authors:  Yoshiki Koriyama; Ayako Furukawa
Journal:  Neurochem Res       Date:  2017-05-18       Impact factor: 3.996

Review 7.  'SNO'-Storms Compromise Protein Activity and Mitochondrial Metabolism in Neurodegenerative Disorders.

Authors:  Tomohiro Nakamura; Stuart A Lipton
Journal:  Trends Endocrinol Metab       Date:  2017-10-30       Impact factor: 12.015

8.  Diverse Redoxome Reactivity Profiles of Carbon Nucleophiles.

Authors:  Vinayak Gupta; Jing Yang; Daniel C Liebler; Kate S Carroll
Journal:  J Am Chem Soc       Date:  2017-04-10       Impact factor: 15.419

Review 9.  Protein S-Nitrosylation as a Therapeutic Target for Neurodegenerative Diseases.

Authors:  Tomohiro Nakamura; Stuart A Lipton
Journal:  Trends Pharmacol Sci       Date:  2015-12-17       Impact factor: 14.819

10.  Nitric Oxide-Dependent Protein Post-Translational Modifications Impair Mitochondrial Function and Metabolism to Contribute to Neurodegenerative Diseases.

Authors:  Tomohiro Nakamura; Stuart A Lipton
Journal:  Antioxid Redox Signal       Date:  2019-12-03       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.